help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wan, Y.
Right arrow Articles by Nordeen, S. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wan, Y.
Right arrow Articles by Nordeen, S. K.
Molecular Endocrinology 15 (1): 17-31
Copyright © 2001 by The Endocrine Society

Separable Features of the Ligand-Binding Domain Determine the Differential Subcellular Localization and Ligand-Binding Specificity of Glucocorticoid Receptor and Progesterone Receptor

Yihong Wan, Kimberly K. Coxe, Varykina G. Thackray, Paul R. Housley and Steven K. Nordeen

Department of Pathology and Program in Molecular Biology (Y.W., V.G.T., S.K.N.) University of Colorado Health Sciences Center Denver, Colorado 80262
Department of Pharmacology and Physiology (K.K.C., P.R.H.) University of South Carolina School of Medicine Columbia, South Carolina 29208

Glucocorticoid receptor (GR) and progesterone receptor (PR) are closely related members of the steroid receptor family of transcription factors. The two receptors share a similar domain structure, substantial sequence identity, DNA binding specificity, and the ability to induce many of the same genes. Despite these similarities, the unliganded GR is localized predominantly in the cytoplasm, while unliganded PR is found predominantly in the nucleus. By expressing green fluorescent protein (GFP)-tagged receptors and assessing subcellular localization in living cells by confocal microscopy, we have investigated the structural basis for the differential localization of GR and PR. By constructing a series of GFP-tagged receptor chimeras between GR and PR, we have shown that multiple features in the N-terminal half of the ligand-binding domain (LBD) are the critical determinants that mandate the differential localization of GR and PR. Replacement of residues encompassing helices 1–5 of GR with those of PR yields a receptor that is nuclear. However, this domain is unable to mediate nuclear import by itself when removed from the context of the receptor. The chimeric receptors also indicate that regions encompassing helices 6 and 7 are key determinants of the ligand binding potential and the transactivation potential of receptors. Thus, the determinants specifying localization of hormone-free receptors are separable from those governing ligand binding character.




This article has been cited by other articles:


Home page
EndocrinologyHome page
H. Becker, A. Sturm, J. E. Bron, K. Schirmer, and N. R. Bury
The A/B Domain of the Teleost Glucocorticoid Receptors Influences Partial Nuclear Localization in the Absence of Hormone
Endocrinology, September 1, 2008; 149(9): 4567 - 4576.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
J.-H. Man, H.-Y. Li, P.-J. Zhang, T. Zhou, K. He, X. Pan, B. Liang, A.-L. Li, J. Zhao, W.-L. Gong, et al.
PIAS3 induction of PRB sumoylation represses PRB transactivation by destabilizing its retention in the nucleus
Nucleic Acids Res., November 14, 2006; 34(19): 5552 - 5566.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
T. M. Price, E. L. Hansen, and T. N. Oliver
Immunofluorescent Localization of a Novel Progesterone Receptor(s) in a T47D-Y Breast Cancer Cell Line Lacking Genomic Progesterone Receptor Expression
Reproductive Sciences, December 1, 2005; 12(8): 610 - 616.
[Abstract] [PDF]


Home page
Endocr. Rev.Home page
K. De Bosscher, W. Vanden Berghe, and G. Haegeman
The Interplay between the Glucocorticoid Receptor and Nuclear Factor-{kappa}B or Activator Protein-1: Molecular Mechanisms for Gene Repression
Endocr. Rev., August 1, 2003; 24(4): 488 - 522.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
K. Kawajiri, T. Ikuta, T. Suzuki, M. Kusaka, M. Muramatsu, K. Fujieda, M. Tachibana, and K.-i. Morohashi
Role of the LXXLL-Motif and Activation Function 2 Domain in Subcellular Localization of Dax-1 (Dosage-Sensitive Sex Reversal-Adrenal Hypoplasia Congenita Critical Region on the X Chromosome, Gene 1)
Mol. Endocrinol., June 1, 2003; 17(6): 994 - 1004.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Miura, R. Ouchida, N. Yoshikawa, K. Okamoto, Y. Makino, T. Nakamura, C. Morimoto, I. Makino, and H. Tanaka
Functional Modulation of the Glucocorticoid Receptor and Suppression of NF-kappa B-dependent Transcription by Ursodeoxycholic Acid
J. Biol. Chem., December 7, 2001; 276(50): 47371 - 47378.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Maccarrone, H. Valensise, M. Bari, N. Lazzarin, C. Romanini, and A. Finazzi-Agro
Progesterone Up-Regulates Anandamide Hydrolase in Human Lymphocytes: Role of Cytokines and Implications for Fertility
J. Immunol., June 15, 2001; 166(12): 7183 - 7189.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
T. Minamino, V. Gaussin, F. J. DeMayo, and M. D. Schneider
Inducible Gene Targeting in Postnatal Myocardium by Cardiac-Specific Expression of a Hormone-Activated Cre Fusion Protein
Circ. Res., March 30, 2001; 88(6): 587 - 592.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2001 by The Endocrine Society